Glimpse Group director awarded stock options

Glimpse Group, Inc. reported that director Tamar Elkeles received two stock option grants as equity compensation, not open-market trades.

Rhea-AI Filing Summary

Glimpse Group, Inc. reported that director Tamar Elkeles received two stock option grants as equity compensation, not open-market trades. On January 1, 2025, Elkeles was granted options for 37,500 shares of common stock at an exercise price of $2.25 per share, vesting in equal monthly increments from January 31, 2025 through December 31, 2025, and expiring on January 1, 2035.

On May 1, 2026, Elkeles was granted additional options for 145,000 shares at an exercise price of $0.69 per share, expiring on May 1, 2036. These options vest with respect to 60,422 shares on May 31, 2026, with the remaining portion vesting in equal monthly increments from June 30, 2026 through December 31, 2026. Following these grants, the filings show option holdings of 37,500 and 145,000 shares for the respective awards.

Insider Trade Summary

Grant/Award: 182,500 shares

Grant/Award 2 txns

Insider Elkeles Tamar

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	145,000	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy)	37,500	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 182,500 contracts (Direct)

Footnotes (2)

1. F1. This option vests in equal monthly increments from 1/31/2025 through 12/31/2025.
2. F2. This option vests with respect to 60,422 shares on 5/31/2026, then vests in equal monthly increments from 6/30/2026 through 12/31/2026.

Key Figures

Option grant size: 37,500 options Exercise price: $2.25 per share Option grant size: 145,000 options +2 more

5 metrics

Option grant size 37,500 options Granted January 1, 2025 to director Tamar Elkeles

Exercise price $2.25 per share 37,500-share option grant, expires January 1, 2035

Option grant size 145,000 options Granted May 1, 2026 to director Tamar Elkeles

Exercise price $0.69 per share 145,000-share option grant, expires May 1, 2036

Initial vesting tranche 60,422 options Portion of 145,000-share grant vesting May 31, 2026

Key Terms

Stock Option (Right to Buy), exercise price, expiration date, vests in equal monthly increments

4 terms

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

exercise price financial

"conversion_or_exercise_price: 0.6900"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-05-01T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vests in equal monthly increments financial

"This option vests in equal monthly increments from 1/31/2025 through 12/31/2025."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Glimpse Group (GGRP) report for Tamar Elkeles?

Glimpse Group reported that director Tamar Elkeles received two stock option grants as equity compensation. The awards cover 37,500 shares and 145,000 shares of common stock, each with its own exercise price, vesting schedule, and long-term expiration date extending into 2035 and 2036.

What are the key terms of Tamar Elkeles’ 37,500-share stock option grant at Glimpse Group (GGRP)?

The 37,500-share option grant has an exercise price of $2.25 per share and expires on January 1, 2035. It vests in equal monthly installments from January 31, 2025 through December 31, 2025, aligning the director’s compensation with company performance over that year.

What are the key terms of Tamar Elkeles’ 145,000-share stock option grant at Glimpse Group (GGRP)?

The 145,000-share option grant has an exercise price of $0.69 per share and expires on May 1, 2036. It vests for 60,422 shares on May 31, 2026, with the remainder vesting in equal monthly installments from June 30, 2026 through December 31, 2026.

Do Tamar Elkeles’ reported Form 4 transactions in Glimpse Group (GGRP) involve open-market buying or selling?

The reported transactions are option grants coded as awards, not open-market purchases or sales. They represent compensation-related acquisitions of derivative securities, giving the director the right to buy Glimpse Group common stock in the future at fixed exercise prices if the options vest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:17 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Elkeles Tamar

(Last) (First) (Middle)

15 WEST 38TH ST

12TH FLOOR

(Street)

NEW YORK NEW YORK 10018

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Glimpse Group, Inc. [ GGRP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.25	01/01/2025		A		37,500		(1)	01/01/2035	Common Stock	37,500	$0	37,500	D
Stock Option (Right to Buy)	$0.69	05/01/2026		A		145,000		(2)	05/01/2036	Common Stock	145,000	$0	145,000	D

Explanation of Responses:

1. This option vests in equal monthly increments from 1/31/2025 through 12/31/2025.

2. This option vests with respect to 60,422 shares on 5/31/2026, then vests in equal monthly increments from 6/30/2026 through 12/31/2026.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ William J. Keneally, Attorney-in-Fact for Tamar Elkeles	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)